You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Johnson and Johnson
Boehringer Ingelheim
Baxter
Harvard Business School

Last Updated: October 19, 2020

DrugPatentWatch Database Preview

Procaine hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for procaine hydrochloride
Recent Clinical Trials for procaine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Oregon Health and Science UniversityEarly Phase 1
McGill University Health CenterN/A
The Adelaide and Meath Hospital, incorporating The National Children's HospitalN/A

See all procaine hydrochloride clinical trials

Medical Subject Heading (MeSH) Categories for procaine hydrochloride

US Patents and Regulatory Information for procaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira PROCAINE HYDROCHLORIDE procaine hydrochloride INJECTABLE;INJECTION 080416-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Gd Searle Llc PROCAINE HYDROCHLORIDE procaine hydrochloride INJECTABLE;INJECTION 086202-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Abraxis Pharm PROCAINE HYDROCHLORIDE procaine hydrochloride INJECTABLE;INJECTION 080421-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Elkins Sinn PROCAINE HYDROCHLORIDE procaine hydrochloride INJECTABLE;INJECTION 083315-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira NOVOCAIN procaine hydrochloride INJECTABLE;INJECTION 085362-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Abraxis Pharm PROCAINE HYDROCHLORIDE procaine hydrochloride INJECTABLE;INJECTION 080384-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bel Mar PROCAINE HYDROCHLORIDE procaine hydrochloride INJECTABLE;INJECTION 080756-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Merck
Harvard Business School
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.